Key result
Higher LVMI and lower e' linked to increased risk of major cardiovascular events in women.
Why the study?
GLS may not predict cardiovascular outcomes as effectively in women, necessitating identification of echocardiographic predictors of cardiovascular morbidity and mortality in women from the general population.
Do echocardiographic parameters such as LVMI and e' predict cardiovascular morbidity and mortality in women from the general population?
Population
1245 women from the general population free of HF and atrial fibrillation
Comparison
Echocardiographic parameters including LVMI, e', and GLS
Design
Cohort study
Follow-up
Median 12.5 years
Authors
Loading...
These markers may refine CV risk stratification in women; leaves open whether they guide therapy or improve outcomes.
Cohort (n=1,245)
Do echocardiographic parameters such as LVMI and e' predict cardiovascular morbidity and mortality in women from the general population?
Hazard Ratio: 1.1 (95% CI 1.03–1.17)
p-value: p=0.004
In women from the general population, left ventricular mass index and diastolic dysfunction (e'), but not global longitudinal strain, are independent predictors of adverse cardiovascular outcomes.
Lundorff et al. (2020) conducted a cohort in general population (n=1,245). Left ventricular mass index (LVMI) and e' was evaluated on composite of acute myocardial infarction, HF, and cardiovascular death (HR 1.10, 95% CI 1.03-1.17, p=0.004). Higher left ventricular mass index (HR 1.10; 95% CI 1.03-1.17) and lower e' (HR 1.53; 95% CI 1.07-2.20) independently predicted acute MI, heart failure, or cardiovascular death in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: